Market Overview:
The global gene therapy drugs market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of genetic diseases, rising demand for novel therapies, and technological advancements in gene therapy drugs. The global gene therapy drugs market is segmented on the basis of type into neuromuscular disease, genetic disease, and other types. The neuromuscular disease segment is expected to account for the largest share of the global gene therapy drugs market in 2018. This segment is projected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this segment can be attributed to increasing awareness about these diseases and advances in technology that are helping improve treatment outcomes for patients with neuromuscular diseases. On the basis of application, the global gene therapy drugs market is divided into hospital and pharmacy segments. The hospital segment accounted for a larger share of the global gene therapy drugs market than the pharmacy segment in 2017.
Product Definition:
Gene therapy drugs are used to treat diseases by repairing or replacing genes. Gene therapy is a promising new way to treat many diseases, including cancer.
Neuromuscular Disease:
Neuromuscular disease (nmda-5) is a group of rare disorders characterized by progressive muscle weakness and degeneration of motor neurons. The most common symptom is muscle twitching or myoclonus, which may be accompanied by vision loss, speech problems, and other neurological symptoms.
The market for neuromuscular disease in gene therapy drugs has been growing at a steady pace over the past few years due to increasing research activities in this field.
Genetic Disease:
A genetic disease is a mutation or variation in the DNA sequence that causes harmful effects on body functions. Genetic diseases are inherited from families and occur due to mutations in the DNA (deoxyribonucleic acid). There are several types of genetic diseases such as cystic fibrosis, hemophilia, and Tay-Sachs disease.
Application Insights:
The gene therapy drugs are classified into two categories, namely hospital and pharmacy. The hospital segment dominated the market in 2017 owing to presence of a large number of patients suffering from rare diseases. Hospital-based gene therapy is primarily used for treatment of severe genetic diseases that cannot be treated by other means such as surgery or chemotherapy.
Pharmacy-based gene therapy is expected to witness lucrative growth over the forecast period due to increasing adoption of these therapies for treating various disorders including cystic fibrosis, hemoglobin disorders, and others. Moreover, growing R&D activities pertaining to delivery via cell line transfer (gene Therapy) will further boost industry growth during the forecast period. For instance, researchers at China¢â‚¬â„¢s Sichuan University have developed an efficient method for delivering genes using induced Pluripotent Stem Cells (iPSCs).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of approved gene therapy drugs, high healthcare expenditure, and increasing awareness about these therapies. Moreover, an increase in R&D initiatives by various companies is expected to fuel growth during the forecast period. For instance, each year Biogen Inc., spends over USD X million on research & development activities pertaining to its portfolio of products including Spinraza (somapacitan).
Asia Pacific is estimated to witness lucrative growth during the forecast period owing to factors such as growing economy and rising disposable income coupled with increased investment by governments for improving healthcare infrastructure in this region. In addition, untapped opportunities due bothto rapid economic development along with regulatory reforms are some other factors driving regional market growth.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyle and dietary habits of people across the world. Chronic diseases are those that are long-term and cannot be cured completely but can be managed with proper treatment. Some common examples of chronic diseases include cancer, heart disease, diabetes, and arthritis. Gene therapy drugs offer a potential cure for these conditions and hence are likely to witness high demand in the coming years.
- Growing awareness about gene therapy: The benefits of gene therapy have been known for many years but only recently has there been a growing awareness about this innovative treatment option among patients and healthcare professionals alike. This is mainly due to the increasing number of clinical studies that have highlighted the potential benefits offered by gene therapy drugs in treating various chronic conditions. As more people become aware about this treatment option, demand for gene therapy drugs is likely to increase significantly in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Gene Therapy Drugs Market Research Report
By Type
Neuromuscular Disease, Genetic Disease, Other
By Application
Hospital, Pharmacy
By Companies
F. Hoffmann-La Roche AG, Novartis International AG, Gilead Sciences, Inc., Ultragenyx Pharmaceutical，Inc., Applied Genetic Technologies Corp, Audentes Therapeutics, BioMarin Pharmaceutical, Bluebird Bio, Nightstar Therapeutics, Sangamo Therapeutics, Spark Therapeutics, uniQure, VBL Therapeutics, Voyager Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
148
Number of Tables & Figures
104
Customization Available
Yes, the report can be customized as per your need.
Global Gene Therapy Drugs Market Report Segments:
The global Gene Therapy Drugs market is segmented on the basis of:
Types
Neuromuscular Disease, Genetic Disease, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F. Hoffmann-La Roche AG
- Novartis International AG
- Gilead Sciences, Inc.
- Ultragenyx Pharmaceutical，Inc.
- Applied Genetic Technologies Corp
- Audentes Therapeutics
- BioMarin Pharmaceutical
- Bluebird Bio
- Nightstar Therapeutics
- Sangamo Therapeutics
- Spark Therapeutics
- uniQure
- VBL Therapeutics
- Voyager Therapeutics
Highlights of The Gene Therapy Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Neuromuscular Disease
- Genetic Disease
- Other
- By Application:
- Hospital
- Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gene Therapy Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gene therapy drugs are medications that use genetic engineering to treat diseases. They work by correcting the genes responsible for a disease.
Some of the major players in the gene therapy drugs market are F. Hoffmann-La Roche AG, Novartis International AG, Gilead Sciences, Inc., Ultragenyx Pharmaceutical，Inc., Applied Genetic Technologies Corp, Audentes Therapeutics, BioMarin Pharmaceutical, Bluebird Bio, Nightstar Therapeutics, Sangamo Therapeutics, Spark Therapeutics, uniQure, VBL Therapeutics, Voyager Therapeutics.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gene Therapy Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Gene Therapy Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Gene Therapy Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Gene Therapy Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Gene Therapy Drugs Market Size & Forecast, 2018-2028
4.5.1 Gene Therapy Drugs Market Size and Y-o-Y Growth
4.5.2 Gene Therapy Drugs Market Absolute $ Opportunity
Chapter 5 Global Gene Therapy Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Gene Therapy Drugs Market Size Forecast by Type
5.2.1 Neuromuscular Disease
5.2.2 Genetic Disease
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Gene Therapy Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Gene Therapy Drugs Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gene Therapy Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gene Therapy Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Gene Therapy Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Gene Therapy Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Gene Therapy Drugs Market Size Forecast by Type
9.6.1 Neuromuscular Disease
9.6.2 Genetic Disease
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Gene Therapy Drugs Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Gene Therapy Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Gene Therapy Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Gene Therapy Drugs Market Size Forecast by Type
10.6.1 Neuromuscular Disease
10.6.2 Genetic Disease
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Gene Therapy Drugs Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Gene Therapy Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Gene Therapy Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Gene Therapy Drugs Market Size Forecast by Type
11.6.1 Neuromuscular Disease
11.6.2 Genetic Disease
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Gene Therapy Drugs Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Gene Therapy Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Gene Therapy Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Gene Therapy Drugs Market Size Forecast by Type
12.6.1 Neuromuscular Disease
12.6.2 Genetic Disease
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Gene Therapy Drugs Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Gene Therapy Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Gene Therapy Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Gene Therapy Drugs Market Size Forecast by Type
13.6.1 Neuromuscular Disease
13.6.2 Genetic Disease
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Gene Therapy Drugs Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gene Therapy Drugs Market: Competitive Dashboard
14.2 Global Gene Therapy Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 F. Hoffmann-La Roche AG
14.3.2 Novartis International AG
14.3.3 Gilead Sciences, Inc.
14.3.4 Ultragenyx Pharmaceutical，Inc.
14.3.5 Applied Genetic Technologies Corp
14.3.6 Audentes Therapeutics
14.3.7 BioMarin Pharmaceutical
14.3.8 Bluebird Bio
14.3.9 Nightstar Therapeutics
14.3.10 Sangamo Therapeutics
14.3.11 Spark Therapeutics
14.3.12 uniQure
14.3.13 VBL Therapeutics
14.3.14 Voyager Therapeutics
